Location · Palo Alto, CA
Clinical trials in Palo Alto, CA
125 recruiting studies have a site in Palo Alto, and 45 of them accept healthy volunteers.
125 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
- Location
- Palo Alto, CA + 21 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingPhase 3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
GRIN Therapeutics, Inc.
- Location
- Palo Alto, CA + 15 other US sites
- Eligibility basics
- Ages 1 mo–18
- Recruiting
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
FemPulse Corporation
- Location
- Palo Alto, CA + 11 other US sites
- Eligibility basics
- Ages 21+ · Women only
- RecruitingPhase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
- Location
- Palo Alto, CA + 13 other US sites
- Eligibility basics
- Ages 6 mo–11
- RecruitingPhase 1/Phase 2
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
Kamau Therapeutics
- Location
- Palo Alto, CA + 5 other US sites
- Eligibility basics
- Ages 12–50
- RecruitingPhase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Novartis Pharmaceuticals
- Location
- Palo Alto, CA + 29 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Palo Alto, CA + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Takeda
- Location
- Palo Alto, CA + 32 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
J-Valve Transfemoral Pivotal Study
JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
- Location
- Palo Alto, CA + 33 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Merck Sharp & Dohme LLC
- Location
- Palo Alto, CA + 8 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Palo Alto, CA + 36 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 1/Phase 2
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
ModernaTX, Inc.
- Location
- Palo Alto, CA + 5 other US sites
- Eligibility basics
- Ages 1+
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Neurona Therapeutics
- Location
- Palo Alto, CA + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
ModernaTX, Inc.
- Location
- Palo Alto, CA + 2 other US sites
- Eligibility basics
- Ages 1+
- Recruiting
Melodi Matrix™ in Breast Reconstruction
Melodi Health, Inc.
- Location
- Palo Alto, CA + 9 other US sites
- Eligibility basics
- Ages 22+ · Women only
- RecruitingPhase 3
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Medicure
- Location
- Palo Alto, CA + 4 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 1/Phase 2
Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
Luxa Biotechnology, LLC
- Location
- Palo Alto, CA + 2 other US sites
- Eligibility basics
- Ages 55+
- Recruiting
Plexaa For Preconditioning: Gender Affirming Mastectomy
Plexaa Ltd
- Location
- Palo Alto, CA
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 4
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Impax Laboratories, LLC
- Location
- Palo Alto, CA + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
SK Life Science, Inc.
- Location
- Palo Alto, CA + 6 other US sites
- Eligibility basics
- Ages 4–55
- RecruitingHealthy volunteers
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
Stanford University
- Location
- Palo Alto, CA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Michael Shy
- Location
- Palo Alto, CA + 17 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteers
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
University of Iowa
- Location
- Palo Alto, CA + 17 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteersPhase 3
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
VA Office of Research and Development
- Location
- Palo Alto, CA + 17 other US sites
- Eligibility basics
- Ages 18–80